Clinical Trial Update: Intravitreal Methotrexate and R2(Rituximab & Lenalidomide) Regimen in Newly-diagnosed Primary Vitreoretinal Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating intravitreal methotrexate with a Rituximab and Lenalidomide regimen for newly diagnosed primary vitreoretinal lymphoma (primary intr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraocular Lymphoma
• Vitreoretinal Lymphoma

Drugs mentioned

• R2 (Rituximab & Lenalidomide) (rituximab and lenalidomide)
• intravitreal methotrexate (methotrexate)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Primary Intraocular Lymphoma | Phase 2 | Status: UNKNOWN